A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription

Genes and Immunity

Volumn 3, Issue 3, 2002, Pages 165-169

  Bream, J H ^a   Ping, A ^a   Zhang, X ^a   Winkler, C ^a   Young, H A ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Gene transcription; Proximal IFN promoter; Single nucleotide polymorphism

Indexed keywords

GAMMA INTERFERON; GUANIDINE; THYMIDINE; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

AFRICAN AMERICAN; ALLELE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; PRIORITY JOURNAL; PROMOTER REGION; REGULATORY MECHANISM; REPORTER GENE; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TRANSCRIPTION REGULATION; ANIMAL; CAUCASIAN; CELL CULTURE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETICS; MOUSE; NEGRO;

AFRICAN CONTINENTAL ANCESTRY GROUP; ANIMALS; CELLS, CULTURED; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE EXPRESSION REGULATION; GENE FREQUENCY; HUMANS; INTERFERON TYPE II; MICE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); TRANSCRIPTION, GENETIC;

EID: 0036559958     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363870     Document Type: Article

References (31)

1. Ye J, Cippitelli M, Dorman L, Ortaldo JR, Young HA. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol 1996; 16: 4744-4753.
2. Kojima H, Aizawa Y, Yanai Y et al. An essential role for NF-kappa B in IL-18-induced IFN-gamma expression in KG-1 cells. J Immunol 1999; 162: 5063-5069.
3. Young HA, Klinman DM, Reynolds DA et al. Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies. Blood 1997; 89: 583-595.
4. Dalton DK, Pitts-Meek S, Keshav S et al. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 1993; 259: 1739-1742.
5. Hayden C, Pereira E, Rye P et al. Mutation screening of interferon-gamma (IFNgamma) as a candidate gene for asthma. Clin Exp Allergy 1997; 27: 1412-1416.
6. Song Z, Casolaro V, Chen R et al. Polymorphic nucleotides within the human IL-4 promoter that mediate overexpression of the gene. J Immunol 1996; 156: 424-429.
7. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
8. Knight JC, Udalova I, Hill AV et al. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145-150.
9. Kostrikis LG, Huang Y, Moore JP et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998; 4: 350-353.
10. Martin MP, Dean M, Smith MW et al. Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998; 282: 1907-1911.
11. Bream JH, Young HA, Rice et al. CCR5 promoter alleles and specific DNA binding factors. Science 1999; 284: 223a.
12. Shin HD, Winkler C, Stephens JC et al. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10. Proc Natl Acad Sci USA 2000; 97: 14467-14472.
13. Liu H, Chao D, Nakayama EE et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci USA 1999; 96: 4581-4585.
14. Winkler C, Modi W, Smith MW et al. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998; 279: 389-393.
15. El-Omar EM, Carrington M, Chow WH et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404: 398-402.
16. Bream JH, Carrington M, O'Toole S et al. Polymorphisms of the human IFNG gene noncoding regions. Immunogenetics 2000; 51: 50-58.
17. Giedraitis V, He B, Hillert J. Mutation screening of the interferon-gamma gene as a candidate gene for multiple sclerosis. Eur J Immunogenet 1999; 26: 257-259.
18. Heinemeyer T, Wingender E, Reuter I et al. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 1998; 26: 362-367.
19. Gonsky R, Deem RL, Bream JH et al. Mucosa-specific targets for regulation of IFN-gamma expression: lamina propria T cells use different cis-elements than peripheral blood T cells to regulate transactivation of IFN-gamma expression. J Immunol 2000; 164: 1399-1407.
20. Chan FK, Lenardo MJ. A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur J Immunol 2000; 30: 652-660.
21. Hadman M, Loo M, Bos TJ. In vivo viral and cellular Jun complexes exhibit differential interaction with a number of in vitro generated 'AP-1- and CREB-like' target sequences. Oncogene 1993; 8: 1895-1903.
22. Herr I, van Dam H, Angel P. Binding of promoter-associated AP-1 is not altered during induction and subsequent repression of the c-jun promoter by TPA and UV irradiation. Carcinogenesis 1994; 15: 1105-1113.
23. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992; 70: 375-387.
24. Vlahov D, Graham N, Hoover D et al. Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count. JAMA 1998; 279: 35-40.
25. Phair J, Jacobson L, Detels R et al. Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr 1992; 5: 490-496.
26. Hilgartner MW, Donfield SM, Willoughby A et al. Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol 1993; 15: 208-218.
27. Goedert JJ, Kessler CM, Aledort LM et al. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med 1989; 321: 1141-1148.
28. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS 1994; 8: 1123-1128.
29. Yu CR, Lin JX, Fink DW et al. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. J Immunol 1996; 157: 126-137.
30. Ng D, Kokot N, Hiura T et al. Macrophage activation by polycyclic aromatic hydrocarbons: evidence for the involvement of stress-activated protein kinases, activator protein-1, and antioxidant response elements. J Immunol 1998; 161: 942-951.
31. Tan TH, Huang GP, Sica A et al. Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. Mol Cell Biol 1992; 12: 4067-4075.